[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 1475 Introduced in Senate (IS)]

<DOC>






118th CONGRESS
  1st Session
                                S. 1475

To amend the Controlled Substances Act to prohibit certain acts related 
to fentanyl, analogues of fentanyl, and counterfeit substances, and for 
                            other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                              May 9, 2023

 Mr. Grassley (for himself, Mrs. Feinstein, and Ms. Hassan) introduced 
the following bill; which was read twice and referred to the Committee 
                            on the Judiciary

_______________________________________________________________________

                                 A BILL


 
To amend the Controlled Substances Act to prohibit certain acts related 
to fentanyl, analogues of fentanyl, and counterfeit substances, and for 
                            other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Stop Pills That Kill Act''.

SEC. 2. DEFINITION.

    In this Act, the term ``counterfeit fentanyl or methamphetamine 
substance'' means a substance that--
            (1) contains fentanyl, any analogue of fentanyl, or 
        methamphetamine; and
            (2) is marketed, sold, or falsely bears the trademark, 
        trade name, or other identifying mark, imprint, number, or any 
        likeness thereof of another product.

SEC. 3. PROHIBITED ACTS.

    Section 403(d)(2) of the Controlled Substances Act (21 U.S.C. 
843(d)(2)) is amended, in the matter preceding subparagraph (A), by 
inserting ``, fentanyl, an analogue of fentanyl, or a counterfeit 
substance'' after ``methamphetamine''.

SEC. 4. COMPREHENSIVE PLAN.

    Not later than 180 days after the date of enactment of this Act, 
the Administrator of the Drug Enforcement Administration shall 
establish and implement an operation and response plan to address 
counterfeit fentanyl or methamphetamine substances that includes--
            (1) strategies to enable and empower Federal law 
        enforcement efforts to investigate and seize counterfeit 
        fentanyl or methamphetamine substances;
            (2) specific ways that education and prevention efforts to 
        stop the use of counterfeit fentanyl or methamphetamine 
        substances will be increased, including how--
                    (A) ongoing efforts, such as Operation Engage, are 
                effective in increasing education and prevention; and
                    (B) how the efforts described in subparagraph (A) 
                are tailored to youth and teen access; and
            (3) an audit of current campaigns, including the ``One Pill 
        Can Kill'' campaign, on counterfeit fentanyl or methamphetamine 
        substances, including a review of data and other available 
        information on how the campaigns can be tailored, adjusted, or 
        improved to better address the flow of counterfeit fentanyl or 
        methamphetamine substances.

SEC. 5. REPORT TO CONGRESS.

    (a) Report.--Not later than 1 year after the date of enactment of 
this Act, and every year thereafter, the Attorney General, in 
consultation with the Administrator of the Drug Enforcement 
Administration and Director of the Office of National Drug Control 
Policy, shall submit to Congress a report on information regarding the 
collection and prosecutions of counterfeit fentanyl or methamphetamine 
substances.
    (b) Contents.--The report required under subsection (a) shall 
include the following:
            (1) Data on the aggregate number of counterfeit fentanyl or 
        methamphetamine substances seized and collected by Federal law 
        enforcement agencies.
            (2) A breakdown on how many counterfeit fentanyl or 
        methamphetamine substances are in pill form.
            (3) A breakdown on which illicit substances are present in 
        the counterfeit fentanyl or methamphetamine substances that are 
        in pill form.
            (4) Data outlining where and when counterfeit fentanyl or 
        methamphetamine substances were seized.
            (5) Data on the charges filed against those manufacturing, 
        distributing, or dispensing, or possessing with the intent to 
        distribute or dispense, a counterfeit fentanyl or 
        methamphetamine substance, particularly in pill form, pursuant 
        to paragraph (1) or (2) of section 401(a) of the Controlled 
        Substances Act (21 U.S.C. 841(a)), unless disclosure of the 
        data would--
                    (A) require unsealing an indictment; or
                    (B) undermine investigations and charges brought by 
                the Department of Justice.
            (6) Data on the convictions and sentences against those who 
        are found guilty under paragraph (1) or (2) of section 401(a) 
        of the Controlled Substances Act (21 U.S.C. 841(a)) as it 
        pertains to counterfeit fentanyl or methamphetamine substances, 
        particularly those in pill form.
            (7) Any prevention measures that the Department of Justice, 
        Drug Enforcement Administration, or Office of National Drug 
        Control Policy are undertaking to limit and reduce the spread 
        of counterfeit fentanyl or methamphetamine substances in pill 
        form, including ongoing public awareness campaigns.
                                 <all>